Skip to main content
SpringerLink
Log in

The Development of New Brain Protective Agents

  • Chapter
Treatment of Cerebral Infarction

Abstract

The brain is known to be particularly susceptible to the effects of ischemia and, once brain tissue has fallen into a state of necrosis due to ischemia, no form of therapy has yet been found to be effective. In recent years, various surgical techniques, such as by-pass surgery and embolectomy, have been developed to treat the ischemic brain, but regardless of how quickly such revascularization methods are employed, in the vast majority of cases a considerable period of time will have elapsed from onset until the completion of revascularization. Not only is it common for the ischemic focus to become infarctic during that period, but when recirculation is achieved in the acute period it is not infrequently the case that brain swelling or hemorrhagic infarction ensues and the patient’s condition actually becomes aggravated18, 32, 117. In light of these facts, we have experimentally investigated—from the clinical neurosurgeon’s perspective—the possibility of developing pharamcological means for preventing the irreversible changes in brain tissue in the brief period between onset and surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adlard BPF (1974) Ascorbic acid in developing brain possible function as an inhibition of lipid peroxidation. Biochem Soc Trans 2: 281–284

    CAS  Google Scholar 

  2. Aldrete JA, Romo-Salas F, Jankovsky L et al (1979) Effect of pretreatment with thiopental and phenytoin on postischemic brain damage in rabbits. Crit Care Med 7: 466–470

    Article  PubMed  CAS  Google Scholar 

  3. Anderson DC, Cranford RE (1979) Corticosteroids in ischemic stroke. Stroke 10: 68–71

    Article  PubMed  CAS  Google Scholar 

  4. Arnfred I, Secher O (1962) Anoxia and barbiturates, tolerance to anoxia in mice influenced by barbiturates. Arch Int Phar-macodyn Ther 139: 67–73

    CAS  Google Scholar 

  5. Artru AA, Michenfelder JD (1980) Cerebral protective, metabolic, and vascular effects of phenytoin. Stroke 11: 377–382

    Article  PubMed  CAS  Google Scholar 

  6. Artru AA, Michenfelder JD (1981) Anoxic cerebral potassium accumulation reduced by phenytoin-mechanism of cerebral protection? Anesth Analg 60: 41–45

    PubMed  CAS  Google Scholar 

  7. Bandaranayake NM, Nemoto EM, Stezoski SW (1978) Rat brain osmolality during barbiturate anesthesia and global brain ischemia. Stroke 9: 249–254

    Article  PubMed  CAS  Google Scholar 

  8. Baskin DS, Hosobuchi Y (1981) Naloxone reversal of ischemic deficits in man. Lancet 8: 272–275

    Article  Google Scholar 

  9. Baskin DS, Kieck CG, Hosobuchi Y (1982) Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effects. Life Sci 31: 2201–2204

    Article  PubMed  CAS  Google Scholar 

  10. Baskin DS, Hosobuchi Y, Grevel JC (1986) Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival. J Neurosurg 64: 99–103

    Article  PubMed  CAS  Google Scholar 

  11. Black KL, Weidler DJ, Jalld NS et al (1978) Delayed pentobarbital therapy of acute focal cerebral ischemia. Stroke 9: 245–254

    Article  PubMed  CAS  Google Scholar 

  12. Bleyaert AL, Nemoto EM, Safar P et al (1978) Thiopental amelioration of brain damage after global ischemia in monkeys. Anesthesiology 49: 390–398

    Article  PubMed  CAS  Google Scholar 

  13. Bodannes RS, Chan PC (1979) Ascorbic acid as a scavenger of singlet oxygen. FEBS Lett 105: 195–196

    Article  PubMed  CAS  Google Scholar 

  14. Bolu RG, Plotkine M, Guenidu C et al (1982) Effect of indomethacin in experimental cerebral ischemia. Pathol Biol 30: 278

    Google Scholar 

  15. Branstron NM, Hope DT, Symon L (1979) Barbiturates in focal ischemia of primate cortex effects on blood flow distribution, evoked potential and extracellular potasium. Stroke 10: 647–653

    Article  Google Scholar 

  16. Broddle W, Nelson SR (1968) The effect of diphenylhydantoin on energy reserve levels in brain. Fed Proc 27: 751

    Google Scholar 

  17. Brown FD, Johns L, Jafer JJ et al (1979) Detailed monitoring of the effect of mannitol following experimental head injury. J Neurosurg 50: 423–432

    Article  PubMed  CAS  Google Scholar 

  18. Caplan LR, Skillman J, Ojemann R et al (1978) Intracerebral hemorrhage following carotid endoarterectomy. A hypertensive complication? Stroke 9: 457–460

    Article  PubMed  CAS  Google Scholar 

  19. Clark LC Jr, Gollan F (1966) Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755–1766

    Article  PubMed  CAS  Google Scholar 

  20. Corkill G, Chikovani OK, McLeish I et al (1976) Timing of pentobarbital administration for brain protection in experimental stroke. Surg Neurol 5: 147–149

    PubMed  CAS  Google Scholar 

  21. Corkill G, Sivalingam S, Reitan JA et al (1978) Dose dependency of the post-insult protective effect of pentobarbital in the canine experimental stroke model. Stroke 9: 10–18

    Article  PubMed  CAS  Google Scholar 

  22. Demopoulos HB (1973) The basis of free radical pathology. Fed Proc 32: 1859–1861

    PubMed  CAS  Google Scholar 

  23. Faden A, Hallenbeck JM, Brown CQ (1982) Treatment of experimental stroke: comparison of naloxone and thyrotropin-releasing hormone. Neurology (Minneap) 32: 1083–1088

    CAS  Google Scholar 

  24. Faden A, Jacobs TP, Smith MT (1984) Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia. J Neurosurg 60: 796–799

    Article  PubMed  CAS  Google Scholar 

  25. Feustel PJ, Ingvar MC, Severinghaus JW (1981) Cerebral oxygen availability and blood flow during middle cerebral artery occlusion: effects of pentobarbital. Stroke 12: 858–863

    Article  PubMed  CAS  Google Scholar 

  26. Flamm ES, Demopoulos HB, Seligman ML et al (1978) Free radicals in cerebral ischemia. Stroke 9: 445–447

    Article  PubMed  CAS  Google Scholar 

  27. Foote CS, Ching TY, Geller GG (1974) Chemistry of singlet oxygen-XVIII: rates of reaction and quenching of a-tocopherol and singlet oxygen. Photochem Photobiol 20: 511–513

    Article  PubMed  CAS  Google Scholar 

  28. Gaines C, Nehls DG, Suess DM et al (1981) Effect of naloxone on experimental stroke in awake monkeys. Neurosurgery 14: 308–314

    Article  Google Scholar 

  29. Gaudet RJ, Levine L (1979) Transient cerebral ischemia and brain prostaglandins. Biochem Biophys Res Commun 86: 893–901

    Article  PubMed  CAS  Google Scholar 

  30. Gaudet RJ, Alam I, Levine A (1980) Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery. J Neurochem 35: 653–658

    Article  PubMed  CAS  Google Scholar 

  31. Goldstein A, Wells BA, Keats AS (1966) Increased tolerance to cerebral anoxia by pentobarbital. Arch Int Parmacodyn Ther 161: 138–143

    CAS  Google Scholar 

  32. Gratzl O, Schmiedek P, Spetzler R et al (1976) Clinical experience with extra-intracranial arterial anastomosis in 65 cases. J Neurosurg 44: 313–324

    Article  PubMed  CAS  Google Scholar 

  33. Hallenbeck JM, Leitch DR, Dutka AJ et al (1982) Prostaglandin I2, indomethacin and heparin promote postischemic neuronal recovery in dogs. Ann Neurol 12: 145–156

    Article  PubMed  CAS  Google Scholar 

  34. Harris RJ, Bayhan M, Branston NM et al (1982) Modulation of the pathophysiology of primate focal cerebral ischemia by indomethacin. Stroke 13: 17–24

    Article  PubMed  CAS  Google Scholar 

  35. Harris RJ, Branston NM, Symon L et al (1982) The effects of a calcium antagonist, nimodipine’ upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischemia. Stroke 13: 759–766

    Article  PubMed  CAS  Google Scholar 

  36. Hoff JT, Smith AL, Hankinson HL et al (1975) Barbiturate protection from cerebral infarction in primates. Stroke 6: 28–33

    Article  PubMed  CAS  Google Scholar 

  37. Holaday JW, D’Amato RJ (1982) Naloxone or THR fails to improve neurological deficits in gerbils models of “stroke”. Life Sci 31: 385–392

    Article  PubMed  CAS  Google Scholar 

  38. Hosobuchi Y, Baskin DS (1982) Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215: 69–71

    Article  PubMed  CAS  Google Scholar 

  39. Hossmann KA, Paschen W, Csiba L (1983) Relationship between calcium accumulation and recovery of cat brain after prolonged cerebral ischemia. J Cereb Blood Flow Metab 3: 346–353

    Article  PubMed  CAS  Google Scholar 

  40. Hubbard JL, Sundt TM (1983) Failure of naloxone to affect focal incomplete cerebral ischemia and collateral blood flow in cats. J Neurosurg 59: 237–244

    Article  PubMed  CAS  Google Scholar 

  41. Johnston IH, Harper AM (1973) The effect of mannitol on cerebral blood flow. An experimental study. J Neurosurg 38: 461–471

    Article  PubMed  CAS  Google Scholar 

  42. Kagawa S, Kosyu K, Yoshimoto T et al (1982) The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study. Surg Neurol 17: 66–70

    Article  PubMed  CAS  Google Scholar 

  43. Karasawa A, Kumada Y, Yamada K et al (1982) Protective effect of flunarizine against hypoxic-anoxia in mice and rats. J Pharmacobiodyn 5: 295–300

    Article  PubMed  CAS  Google Scholar 

  44. Kassel NF, Baumann KW, Hitchon PW et al (1982) The effect of high dose mannitol on cerebral blood flow in dogs with normal intracranial pressure. Stroke 13: 59–61

    Article  Google Scholar 

  45. Kayama T, Mizoi K, Suzuki J (1981) A canine model of a completely ischemic brain regulated with the perfusion method. Surg Neurol 16: 167–172

    Article  Google Scholar 

  46. Kazda S, Hoffmeister F, Garthoff B et al (1973) Prevention of the postischemic impaired reperfusion of the brain by nimodipine (BAY e 9736). Acta Neurol Scand [Suppl] 60: 302–303

    Google Scholar 

  47. Kennedy C, Grave GD, Jehle JW et al (1972) The effect of diphenylhydantoin on local cerebral blood flow. Neurology (Abstr) 22: 451

    Google Scholar 

  48. Koreh K, Seligman ML, Flamm ES et al (1981) Lipid antioxidant properties of naloxone in vivo. Biochem Biophys Res Commun 102: 1317–1322

    Article  PubMed  CAS  Google Scholar 

  49. Lavyne MH, Hariri RJ, Tankosic T et al (1983) Effect of low dose y-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat. Neurosurgery 12: 430–434

    Article  PubMed  CAS  Google Scholar 

  50. Levy DM, Brierley JB (1979) Delayed pentobarbital administration limits ischemic brain damage in gerbils. Ann Neurol 5: 59–64

    Article  PubMed  CAS  Google Scholar 

  51. Levy R, Feustel P, Severinghaus J et al (1982) Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in cats. Life Sci 31: 2205–2208

    Article  PubMed  CAS  Google Scholar 

  52. Little JR (1978) Modification of acute focal ischemia by treatment with mannitol. Stroke 9: 4–9

    Article  PubMed  CAS  Google Scholar 

  53. Little JR (1979) Treatment of acute focal cerebral ischemia with intermittent low dose mannitol. Neurosurgery 5: 687–691

    Article  PubMed  CAS  Google Scholar 

  54. Majewska MD, Strosznajder J, Laza-rewicz J (1978) Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation on mitochondrial phospholipids. Brain Res 158: 423–434

    Article  PubMed  CAS  Google Scholar 

  55. Meyer JS, Fukuuchi Y, Shimazu K et al (1982) Abnormal hemispheric blood flow and metabolism in cerebrovascular disease. Part 2: Therapeutic trials with 5% C02 inhalation, hyperventilation, and intravenous infusion of THAM and mannitol. Stroke 3: 157–167

    Article  Google Scholar 

  56. Michenfelder JD, Theye RA (1970) The effects of anesthesia and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation. Anesthesiology 33: 430–439

    Article  PubMed  CAS  Google Scholar 

  57. Michenfelder JD, Theye RA (1973) Cerebral protection by thiopental during hypoxic. Anesthesiology 39: 510–517

    Article  PubMed  CAS  Google Scholar 

  58. Michenfelder JD, Milde JH (1975) Influence of anesthetics on metabolic, functional and pathological responses to regional cerebral ischemia. Stroke 6: 405–410

    Article  PubMed  CAS  Google Scholar 

  59. Michenfelder JD, Milde JH, Sundt TM Jr (1976) Cerebral protection by barbiturate anesthesia. Use after middle cerebral artery occlusion in j ava monkeys. Arch Neurol 3 3: 345–350

    Article  Google Scholar 

  60. Miller CL, Lampard DG, Alexander K et al (1980) Local cerebral blood flow following transient cerebral ischemia. I. Onset of impaired reperfusion within the first hour following global ischemia. Stroke 11: 534–541

    Article  PubMed  CAS  Google Scholar 

  61. Mitsuno T (1986) Studies on perfluorochemical emulsion as artificial blood. Surg Ther (Osaka) 34: 75–84

    Google Scholar 

  62. Mizoi K, Yoshimoto T, Suzuki J (1981) Experimental study of new cerebral protective substances-functional recovery of severe incomplete ischemic brain lesions, pretreated with mannitol and perfluorochemicals. Acta Neurochir (Wien) 56: 157–166

    Article  CAS  Google Scholar 

  63. Moseley JI, Laurent JP, Molinari GF (1975) Barbiturate attenuation of clinical course and pathologic lesions in a primate stroke model. Neurology 25: 870–874

    PubMed  CAS  Google Scholar 

  64. Naito R, Yokohama K (1978) Perfluorochemical blood substitutes. Fluosol-43, Fluosol-DA 20% and 35%. Technical Information Series No 5. The Green Cross Corporation, 1–177, June 30

    Google Scholar 

  65. Newberg LA, Steen PA, Milde JH et al (1984) Failure of flunarizine to improve cerebral blood flow or neurologic recovery in a canine model of complete cerebral ischemia. Stroke 15: 666–671

    Article  PubMed  CAS  Google Scholar 

  66. Nilsson L (1971) The influence of barbiturate anesthesia upon the energy state and upon acid-base parameters of the brain in arterial hypotension and asphyxia. Acta Neurol Scand 47: 233–253

    Article  PubMed  CAS  Google Scholar 

  67. Nishikimi M (1975) Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem Biophys Res Commun 63: 463–467

    Article  PubMed  CAS  Google Scholar 

  68. Nordstrom CH, Siesjo BK (1978) Effects of phenobarbital in cerebral ischemia. Part I: Cerebral energy metabolism during pronounced incomplete ischemia. Stroke 9: 327–335

    Article  PubMed  CAS  Google Scholar 

  69. Nordstrom CH, Rehncrona S, Siejo BK (1978) Effects of phenobarbital in cerebral ischemia. Part II: Restitution of cerebral energy state, as well as of glycolytic metabolites, citric acid cycle intermediates and associated amino acids after pronounced incomplete ischemia. Stroke 9: 335–343

    Article  PubMed  CAS  Google Scholar 

  70. Nugent M, Artru AA, Michenfelder JD (1982) Cerebral metabolic vascular and protective effects of midazolam maleate. Anesthesiology 56: 172–176

    Article  PubMed  CAS  Google Scholar 

  71. Ochiai C, Asano T, Takakura K et al (1982) Mechanism of cerebral protection by pentobarbital and nizofenone correlated with the course of local cerebral blood flow changes. Stroke 13: 788–796

    Article  PubMed  CAS  Google Scholar 

  72. Ogawa A, Seki H’ Mizoi K et al (1979) Circulatory dynamics in experimental focal cerebral infarction. Acta Neurol Scand [Suppl] 72: 284–285

    Google Scholar 

  73. Ogawa A, Seki H, Yoshimoto T et al (1982) Experimental focal cerebral infarction. Part 1: Hemodynamics at the center of the focal cerebral infarction following recirculation. Jpn J Stroke 4: 1–9 (Eng Abstr)

    Article  Google Scholar 

  74. Pulsinelli WA, Plum F, Brierley JB (1979). Barbiturate exacerbation of ischemic brain damage following bilateral hemispheric ischemia in the rat. Ann Neurol 6: 156 (Abstr)

    Google Scholar 

  75. Raichel ME (1983) The pathophysiology of brain ischemia. Ann Neurol 13: 2–10

    Article  Google Scholar 

  76. Redapath JL, Willson RL (1973) Reducing compounds in radioprotection and radio-sensitization: model experiments using ascorbic acid. Int J Radiat Biol 23: 51–65

    Article  Google Scholar 

  77. Reedy DP, Little JR, Capro JA et al (1983) Effects of verapamil on acute focal cerebral ischemia. Neurosurgery 12: 272–276

    Article  PubMed  CAS  Google Scholar 

  78. Roba J, Reuse-Blom S, Lambelin G (1976) In vivo antispasmodic activity of suloctidil. Arch Int Phamacodyn Ther 221: 54–59

    CAS  Google Scholar 

  79. Roba J, Roncucci R, Lambelin G (1977) Parmacological properties of suloctidil. Acta Clin Belg 32: 3–7

    PubMed  CAS  Google Scholar 

  80. Roy MW, Dempsey RJ, Meyer KL et al (1985) Effect of verapamil and diltiazem on acute stroke in cats. J Neurosurg 63: 929–936

    Article  PubMed  CAS  Google Scholar 

  81. Sawynok J, Pinsky C, LaBella FS (1979) Mini review on the specificity of naloxone as an opiate antagonist. Life Sci 25: 1621–1632

    Article  PubMed  CAS  Google Scholar 

  82. Secher O, Wilhjem BI (1968) The protective action of anesthetics against hypoxia. Can Andes Soc J 15: 166–182

    Google Scholar 

  83. Seki H, Yoshimoto T, Ogawa A et al (1983) Effect of mannitol on rCBF in canine thalamic ischemia-an experimental study. Stroke 14: 46–50

    Article  PubMed  CAS  Google Scholar 

  84. Selman WR, Spetzler RF, Roessmann UR et al (1981) Barbiturate-induced coma therapy for focal cerebral ischemia. J Neurosurg 55: 220–226

    Article  PubMed  CAS  Google Scholar 

  85. Selman WR, Spetzler RF, Roski RA et al (1981) Regional cerebral blood flow following middle cerebral artery occlusion and barbiturate therapy in baboons. J Cereb Blood Flow Metab [Suppl 1] 1: 214–215

    Google Scholar 

  86. Selman WR, Spetzler RF, Roski RA et al (1982) Barbiturate coma in focal cerebral ischemia: relationship of protection of timing of therapy. J Neurosurg 56: 685–690

    Article  PubMed  CAS  Google Scholar 

  87. Shiu GK, Nemoto EM (1981) Barbiturate attenuation of brain free fatty acid liberation during global ischemia. J Neurochem 37: 1448–1456

    Article  PubMed  CAS  Google Scholar 

  88. Shiu GK, Nemoto EM, Nemmer J (1983) Dose of thiopental’ pentobarbital and phenytoin for maximal therapeutic effects in cerebral ischemic anoxia. Crit Care Med 11: 452–459

    Article  PubMed  CAS  Google Scholar 

  89. Shohami E, Rosenthal T, Lavy S (1982) The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. Stroke 13: 494–499

    Article  PubMed  CAS  Google Scholar 

  90. Siesjo BK (ed) (1978) Brain energy metabolism. John Wiley and Sons, New York

    Google Scholar 

  91. Siesjo BIC (1981) Cell damage in the brain-a speculative synthesis. J Cereb Blood Flow Metab 1: 155–185

    Article  PubMed  CAS  Google Scholar 

  92. Siesjo BK (1984) Cerebral circulation and metabolism. J Neurosurg 60: 883–908

    Article  PubMed  CAS  Google Scholar 

  93. Simeone FA, Frazer G, Lawner P (1979) Ischemic brain edema: comparative effects of barbiturates and hypothermia. Stroke 10: 8–12

    Article  PubMed  CAS  Google Scholar 

  94. Smith AL, Hoff JT, Nielsen SL et al (1974) Barbiturate protection in acute focal cerebral ischemia. Stroke 5: 1–7

    Article  PubMed  CAS  Google Scholar 

  95. Smith DS, Rehncrona S, Siesjo BIC (1980) Inhibitor effects of different barbiturates on lipid peroxidation in brain tissue in vitro: comparison with the effects of promethazine and chlorpromazine. Anesthesiology 53: 186–194

    Article  PubMed  CAS  Google Scholar 

  96. Smith DS, Rehncrona S, Siesjo BK (1980) Barbiturates as protective agents in brain ischemia and as free radical scavenger in vitro. Acta Physiol Scand [Suppl] 492:129–134

    CAS  Google Scholar 

  97. Spector RG (1972) Effects offormyl tetra-hydrofolic acid and noradrenaline on the oxygen consumption of rat brain synaptosome-mitochondrial preparation. Br J Pharmacol 44: 279–285

    PubMed  CAS  Google Scholar 

  98. Steen PA, Michenfelder JD (1978) Cerebral protection with barbiturates. Relation to anesthetic effect. Stroke 9:140–142

    Article  PubMed  CAS  Google Scholar 

  99. Steen PA, Milde JH, Michenfelder JD (1978) No barbiturate protection in a dog model of complete cerebral ischemia. Ann Neurol 5: 343–349

    Article  Google Scholar 

  100. Steen PA, Michenfelder JD (1979) Barbiturate protection in tolerant and nontoler-ant hypoxic mice: comparison with hypothermic protection. Anesthesiology 50: 404–408

    Article  PubMed  CAS  Google Scholar 

  101. Steen PA, Newberg LA, Milde JH et al (1983) Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 3: 38–43

    Article  PubMed  CAS  Google Scholar 

  102. Suzuki O, Yagi K (1973) Formation of lipoperoxide in brain edema by cold injury. Experientia 30: 248

    Article  Google Scholar 

  103. Suzuki J (1974) Method of prolongation of temporary stopping of the cerebral blood flow. Presidential address. 33rd Annual Meeting of Japan Neurosurgical Society. Sendai, Japan, Oct 22

    Google Scholar 

  104. Suzuki J, Tanaka S, Yoshimoto T et al (1980) Recirculation in the acute period of cerebral infarction. Experimental research on brain swelling and its suppression by using mannitol or glycerol. Acta Neurochir (Wien) 54: 219–231

    Article  CAS  Google Scholar 

  105. Suzuki J, Yoshimoto T, Tanaka S et al (1980) Production of various models of cerebral infarction in the dog by means of occlusion of intracranial trunk arteries. Stroke 11: 337–341

    Article  PubMed  CAS  Google Scholar 

  106. Suzuki J, Tanaka S, Yoshimoto T (1981) Suppression of brain swelling with mannitol’ and perfluorochemicals-an experimental study. Acta Neurochir (Wien) 58: 149–160

    Article  CAS  Google Scholar 

  107. Suzuki J, Fujimoto S, Mizoi K et al (1984) The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 15: 672–679

    Article  PubMed  CAS  Google Scholar 

  108. Suzuki J, Imaizumi S, Kayama T (1985) Chemiluminescence in hypoxic brain. The 2nd report: cerebral protective effect of mannitol, vitamin E and glucocorticoid. Stroke 16: 695–700

    Article  PubMed  CAS  Google Scholar 

  109. Tamura A, Asano T, Sano K et al (1979) Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital. A comparative study in chronic middle cerebral artery occlusion in cats. Stroke 10: 126–134

    Article  PubMed  CAS  Google Scholar 

  110. Tappel AL (1973) Lipid peroxidation damage to cell components. Fed Proc 32: 1870–1874

    PubMed  CAS  Google Scholar 

  111. Van Reempts J, Borgers M, Van Eyndhofen J et al (1982) Protective effects of etomidate in hypoxic-ischemic brain damage in the morphologic assessment. Exp Neurol 76: 181–195

    Article  PubMed  Google Scholar 

  112. Watanabe T, Yoshimoto T, Ogawa A et al (1979) The effect of mannitol in preventing the development of cerebral infarction. An electron microscopical investigation. No Shinkei Geka 7: 859–866 (Eng Abstr)

    PubMed  CAS  Google Scholar 

  113. Watanabe T, Yoshimoto T, Suzuki J et al (1984) Suppressive effect of mannitol upon cerebral infarction formation. An electron microscopical investigation. In: Go KG, Bethmann A (eds) Recent progress in the study and therapy of brain edema. Plenum Press, New York, pp 551–554

    Google Scholar 

  114. White BC, Gadztnski DS, Hoehner PJ et al (1982) Effect of flunarizine on canine cerebral cortical blood flow and vascular resistance post cardiac arrest. Ann Emerg Med 11: 119–126

    Article  PubMed  CAS  Google Scholar 

  115. Wiernsperger N, Gygay P, Hofmann A (1984) Calcium antagonist PY 108–068: demonstration of its efficacy in various types of experimental brain ischemia. Stroke 15: 679–685

    Article  PubMed  CAS  Google Scholar 

  116. Wolfe LS (1982) Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derviatives of carbon-20 unsaturated fatty acids. J Neurochem 38: 1–14

    Article  PubMed  CAS  Google Scholar 

  117. Wylie EJ, Hein MF, Adams JE (1964) Intracranial hemorrhage following surgical revascularization for treatment of acute strokes. J Neurosurg 21: 212–215

    Article  PubMed  CAS  Google Scholar 

  118. Yasuda H, Shimada O, Nakajima A et al (1981) Cerebral protective effect and radical scavenging action. J Neurochem 37: 934–938

    Article  PubMed  CAS  Google Scholar 

  119. Yatsu FM, Diamond I, Graziano C et al (1972) Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital). Stroke 3: 726–732

    Article  PubMed  CAS  Google Scholar 

  120. Yoshida S, Inoh S, Asano T et al (1980) Effect of transient ischemia on free fatty acids and phospholipids in gerbil brain. Lipid peroxidation as a possible cause of postischemic injury. J Neurosurg 53: 323–331

    Article  PubMed  CAS  Google Scholar 

  121. Yoshimoto T, Sakamoto T, Suzuki J et al (1978) Experimental cerebral infarction. Part 1: Production of thalamic infarction in dogs. Stroke 9: 211–214

    Article  PubMed  CAS  Google Scholar 

  122. Yoshimoto T, Sakamoto T, Watanabe T et al (1978) Experimental cerebral infarction. Part 3: Protective effect of mannitol in thalamic infarction in dogs. Stroke 9: 217–218

    Article  PubMed  CAS  Google Scholar 

  123. Zabramski JM, Spetzler RF, Selman WR et al (1984) Naloxone therapy during focal cerebral ischemia. Evaluation in a primate model. Stroke 15: 621–626

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurosurgery, Institute for Brain Diseases, Tohoku University School of Medicine, Nagamachi, Sendai, Japan

    Professor Jiro Suzuki M.D.

Authors
  1. Professor Jiro Suzuki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag/Wien

About this chapter

Cite this chapter

Suzuki, J. (1987). The Development of New Brain Protective Agents. In: Treatment of Cerebral Infarction. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8861-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-8861-3_7

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-8863-7

  • Online ISBN: 978-3-7091-8861-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation